Consent for publication The authors give their consents for the publication of contents of this paper to be published in the Cellular and Molecular Life Sciences
However, we previously reported intracellular levels of these mediators in relation to GPX4 activity (7) that are likely similarly altered here
This interaction could potentially limit the cellular absorption of OxLDL, which is reputed to contribute to atherogenic processes
DMEM was originally formulated with low glucose (1 g/L) and sodium pyruvate, but is often used with higher glucose levels, with or without sodium pyruvate
Used to boost energy and manage a number of medical conditions
Developing and testing a new drug is expensive, and companies count on recouping their costs by having, in effect, a monopoly on the market for a new drug